MX2022011697A - Inhibidores de ciclofilina y usos de los mismos. - Google Patents
Inhibidores de ciclofilina y usos de los mismos.Info
- Publication number
- MX2022011697A MX2022011697A MX2022011697A MX2022011697A MX2022011697A MX 2022011697 A MX2022011697 A MX 2022011697A MX 2022011697 A MX2022011697 A MX 2022011697A MX 2022011697 A MX2022011697 A MX 2022011697A MX 2022011697 A MX2022011697 A MX 2022011697A
- Authority
- MX
- Mexico
- Prior art keywords
- cyclophilin inhibitors
- cyclophilin
- inhibitors
- organ
- disorders
- Prior art date
Links
- 239000000134 cyclophilin inhibitor Substances 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010053159 Organ failure Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Los compuestos definidos por la fórmula 4 se utilizan como inhibidores de ciclofilina para la prevención o tratamiento de enfermedades o trastornos, tal como lesión de órganos o insuficiencia orgánica.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2020081295 | 2020-03-26 | ||
CN2021078391 | 2021-03-01 | ||
PCT/CN2021/083013 WO2021190601A1 (en) | 2020-03-26 | 2021-03-25 | Cyclophilin inhibitors and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022011697A true MX2022011697A (es) | 2022-10-07 |
Family
ID=77891510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022011697A MX2022011697A (es) | 2020-03-26 | 2021-03-25 | Inhibidores de ciclofilina y usos de los mismos. |
Country Status (12)
Country | Link |
---|---|
US (2) | US20230174583A1 (es) |
EP (2) | EP4126904A1 (es) |
JP (2) | JP2023518777A (es) |
KR (2) | KR20220158761A (es) |
CN (2) | CN115335389A (es) |
AU (1) | AU2021240762A1 (es) |
BR (1) | BR112022018929A2 (es) |
CA (2) | CA3172601A1 (es) |
IL (1) | IL296586A (es) |
MX (1) | MX2022011697A (es) |
TW (1) | TW202144379A (es) |
WO (2) | WO2021190604A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111449050A (zh) * | 2019-01-20 | 2020-07-28 | 睿诺医疗科技(上海)有限公司 | 环孢菌素类似物及其用途 |
GB202207348D0 (en) * | 2022-05-19 | 2022-07-06 | Cypralis Ltd | Macrocyclic compounds and uses thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200703157B (en) * | 2004-10-01 | 2008-08-27 | Scynexis Inc | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
CN101511357B (zh) * | 2006-05-19 | 2011-11-02 | 西尼克斯公司 | 环孢菌素类化合物及其组合物在制备治疗和预防眼部疾病的药物中的应用 |
WO2008143996A1 (en) * | 2007-05-18 | 2008-11-27 | Scynexis, Inc. | New chemical processes |
US9890198B2 (en) * | 2010-12-03 | 2018-02-13 | S&T Global Inc. | Cyclosporin derivatives and uses thereof |
DE102011111991A1 (de) * | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | Neue Cyclosporin-Derivate |
US20140213508A1 (en) * | 2012-10-19 | 2014-07-31 | Scynexis, Inc. | Antiviral macrocycles |
GB201222455D0 (en) * | 2012-12-13 | 2013-01-30 | Perioc Ltd | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease |
CN106902346A (zh) * | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技(武汉)有限公司 | 药物组合物及其制药用途 |
CN106902347A (zh) * | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技(武汉)有限公司 | 亲环孢素抑制剂的用途 |
EP3458470A4 (en) * | 2016-05-17 | 2020-04-22 | S&T Global Inc. | NEW CYCLOSPOR DERIVATIVES AND USES THEREOF |
GB201711749D0 (en) * | 2017-07-21 | 2017-09-06 | Cypralis Ltd | Cyclosporin analogues and uses thereof |
WO2020037530A1 (en) * | 2018-08-22 | 2020-02-27 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Crystalline form of compound and uses thereof in medicine |
CN111449050A (zh) * | 2019-01-20 | 2020-07-28 | 睿诺医疗科技(上海)有限公司 | 环孢菌素类似物及其用途 |
-
2021
- 2021-03-25 BR BR112022018929A patent/BR112022018929A2/pt unknown
- 2021-03-25 WO PCT/CN2021/083016 patent/WO2021190604A1/en unknown
- 2021-03-25 CA CA3172601A patent/CA3172601A1/en active Pending
- 2021-03-25 KR KR1020227036440A patent/KR20220158761A/ko unknown
- 2021-03-25 WO PCT/CN2021/083013 patent/WO2021190601A1/en unknown
- 2021-03-25 US US17/906,348 patent/US20230174583A1/en active Pending
- 2021-03-25 JP JP2022556478A patent/JP2023518777A/ja active Pending
- 2021-03-25 KR KR1020227036439A patent/KR20220158760A/ko unknown
- 2021-03-25 JP JP2022556477A patent/JP2023518776A/ja active Pending
- 2021-03-25 CN CN202180023394.0A patent/CN115335389A/zh active Pending
- 2021-03-25 IL IL296586A patent/IL296586A/en unknown
- 2021-03-25 CA CA3172535A patent/CA3172535A1/en active Pending
- 2021-03-25 TW TW110110800A patent/TW202144379A/zh unknown
- 2021-03-25 MX MX2022011697A patent/MX2022011697A/es unknown
- 2021-03-25 EP EP21776582.5A patent/EP4126904A1/en active Pending
- 2021-03-25 AU AU2021240762A patent/AU2021240762A1/en active Pending
- 2021-03-25 CN CN202180023172.9A patent/CN115298199A/zh active Pending
- 2021-03-25 EP EP21776894.4A patent/EP4126905A1/en active Pending
-
2022
- 2022-09-16 US US17/946,071 patent/US20230110497A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN115298199A (zh) | 2022-11-04 |
EP4126905A1 (en) | 2023-02-08 |
AU2021240762A1 (en) | 2022-10-06 |
KR20220158760A (ko) | 2022-12-01 |
TW202144379A (zh) | 2021-12-01 |
IL296586A (en) | 2022-11-01 |
BR112022018929A2 (pt) | 2022-12-06 |
JP2023518776A (ja) | 2023-05-08 |
JP2023518777A (ja) | 2023-05-08 |
US20230174583A1 (en) | 2023-06-08 |
US20230110497A1 (en) | 2023-04-13 |
WO2021190601A1 (en) | 2021-09-30 |
CA3172601A1 (en) | 2021-09-30 |
KR20220158761A (ko) | 2022-12-01 |
CA3172535A1 (en) | 2021-09-30 |
CN115335389A (zh) | 2022-11-11 |
EP4126904A1 (en) | 2023-02-08 |
WO2021190604A1 (en) | 2021-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023004923A (es) | Compuestos heterociclicos como inmunomoduladores. | |
MX2021004431A (es) | Procesos novedosos. | |
MX2021009246A (es) | Inmunomoduladores, composiciones y metodos de los mismos. | |
PH12020551062A1 (en) | 1,2,4-oxadiazole compounds as inhibitors of cd47 signalling pathways | |
CL2020002146A1 (es) | Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer. | |
MX2022015272A (es) | Inhibidores de la proteina kras g12c y usos de estos. | |
CR20210563A (es) | Compuestos y métodos para el tratamiento de covid-19 | |
TN2020000125A1 (en) | Amino-fluoropiperidine derivative as kinase inhibitor | |
MY196572A (en) | Amino-Methyl Piperidine Derivative as Kinase Inhibitor | |
SA520412335B1 (ar) | مشتقات أوكسي فلورو ببريدين كمثبط كيناز | |
MX2021012706A (es) | Inhibidores de dihidroorotato deshidrogenasa. | |
WO2019226213A3 (en) | AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS | |
MX2022011697A (es) | Inhibidores de ciclofilina y usos de los mismos. | |
MX2023001997A (es) | Compuestos biciclicos, composiciones y usos de los mismos. | |
WO2019169333A8 (en) | Afibrotic compounds, devices, and uses thereof | |
MX2020012281A (es) | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas. | |
CR20230362A (es) | Inhibidores de cdk2 y métodos de uso de los mismos | |
MX2022007285A (es) | Compuestos, polimeros, dispositivos y usos de los mismos. | |
MX2023001296A (es) | Composiciones y metodos para tratar enfermedades y trastornos. | |
CL2023001339A1 (es) | Un inhibidor de magl. | |
MX2023006578A (es) | Heteroaril-acetilenos, sus composiciones farmacéuticas y sus aplicaciones terapéuticas. | |
MX2020011826A (es) | Composiciones de combinacion que comprenden compuestos de bisfluoroalquil-1,4-benzodiazepinona y metodos de uso de las mismas. | |
PH12021550258A1 (en) | Cdk8/19 inhibitors | |
ZA202100955B (en) | Thrombin inhibitors, formulations, and uses thereof | |
MX2022012404A (es) | Composiciones que comprenden 15-hepe para tratar o prevenir trastornos hematológicos y/o enfermedades relacionadas. |